Literature DB >> 8149941

Influence of different doses of interferon-alpha-2b on the blood plasma levels of 5-fluorouracil.

M J Czejka1, J Schüller, W Jäger, U Fogl, C Weiss.   

Abstract

The blood plasma levels of 5-fluorouracil (5FU) after i.v. administration have been determined without and under the influence of 1, 5 or 9 million units (MU) preadministered interferon (IFN) in patients with gastrointestinal carcinoma. The co-administration of 9 MU IFN causes a doubled increase of the 5FU serum concentrations combined with a statistically significant change of the pharmacokinetics of 5FU for c0, AUC, Vd and Cltot (P < 0.005). A similar effect with distinctly increased serum concentrations could be observed for the preadministration of 5 mU IFN whereby c0 and AUC were elevated significantly (P < 0.05), but not Vd, Cltot and cd. The preadministration of 1 MU IFN also leads to higher plasma levels, but no changes in the pharmacokinetics of 5FU could be calculated (P > 0.05). A linear correlation between the IFN dose and the pharmacokinetic parameters c0 (R = 0.958), AUC0-120 (R = 0.948), Vd (R = 0.941) and Cltot (R = 0.963) of 5FU could be found (P < 0.05), but not for the coefficient of distribution and t1/2el. The results indicate that the pharmacokinetics of 5FU might be influenced by the preadministered IFN dose.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8149941     DOI: 10.1007/BF03188803

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  6 in total

1.  Rapid and simple high-performance liquid chromatographic assay for 5'-fluorouracil in plasma for bioavailability studies.

Authors:  W Jäger; M J Czejka; J Schüller; U Fogl; E Czejka; H Lackner
Journal:  J Chromatogr       Date:  1990-11-16

2.  Influence of interferon-alpha-2b on the blood-plasma levels of intraarterial administered fluorouracil.

Authors:  M J Czejka; J Schuller; U Fogl; C Weiss
Journal:  Pharmazie       Date:  1991-11       Impact factor: 1.267

3.  Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinoma.

Authors:  S Wadler; P H Wiernik
Journal:  Semin Oncol       Date:  1990-02       Impact factor: 4.929

4.  Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects.

Authors:  S Wadler; R Wersto; V Weinberg; D Thompson; E L Schwartz
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

5.  Clinical pharmacokinetics of 5-fluorouracil. Influence of the biomodulating agents interferon, dipyridamole and folinic acid alone and in combination.

Authors:  M J Czejka; W Jäger; J Schüller; U Fogl; C Weiss; G Schernthaner
Journal:  Arzneimittelforschung       Date:  1993-03

6.  [Pharmacokinetic aspects of the combination of interferon-alpha-2b and folic acid with fluorouracil].

Authors:  M J Czejka; W Jäger; J Schüller; U Fogl; G Schernthaner
Journal:  Arzneimittelforschung       Date:  1991-08
  6 in total
  1 in total

1.  Disposition of 5-formyl- and 5-methyltetrahydrofolic acid in serum after i.v. bolus of calcium folinate: pharmacokinetic drug interaction with preadministered interferon-alpha-2b.

Authors:  M J Czejka; J Schüller; C Weiss; S Bandak; B Meyer; D Simon
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Oct-Dec       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.